Opko Sees Huge Long-Term Impact From Prolor Deal

Aug. 21 (Bloomberg) -- Phillip Frost, chief executive officer of Opko Health Inc., talks about its share listing on the Tel Aviv Stock Exchange today and the acquisition of Israeli drugmaker Prolor Biotech Inc. He speaks with Elliott Gotkine on Bloomberg Television's "On the Move." (Source: Bloomberg)
Will Commodity Defaults Spread?
42:45 - Bloomberg’s Lisa Abramowicz examines the commodities market and high yield bonds. She speaks with Bloomberg’s Alix Steel on “Bloomberg Markets.” (Source: Bloomberg)
  • New Apple TV to Arrive This Fall
  • Where Are Oil Prices Heading After 2Q Losses?
  • What Are Cadillac Dealers Demanding from Nysschen?